Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Lubin Family Foundation Scholar Award Symposium highlights tomorrow’s cancer research leaders

A group of people at the Lubin Symposium

Fall 2026
By Hannah White Hannah
Photography by Michael Blanchard

The Richard K. Lubin Family Foundation’s commitment to advancing cancer research was on display at the Lubin Family Foundation Scholar Award Annual Symposium, held May 6, 2026, at Dana-Farber Cancer Institute. The annual event highlighted groundbreaking research from Lubin Scholars, whose work spans disease areas including immunotherapy, genomics, lymphoma, glioblastoma, multiple myeloma, and ovarian cancer. Nobel Laureate William G. Kaelin Jr., MD, scientific director of the Lubin Family Foundation Scholar Award Program and the Sidney Farber, MD, Professor of Medicine at Harvard Medical School and Dana-Farber, welcomed attendees, and Richard K. Lubin shared remarks celebrating the foundation’s commitment to supporting early career physician-scientists. Throughout the afternoon, Lubin Scholars and their mentors demonstrated how Dana-Farber is equipping the next generation of physician-scientists to advance discoveries that will shape the future of cancer care.

,
Copy link
Powered by Social Snap